Hospital Universitario 12 de Octubre

Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database (2026) Burja B, Boubaya M, Bruni C, Christ L, Ananyeva LP, Atzeni F, Bergmann C, et al. Journal article Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2026) Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, et al. Journal article, Review article Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease (2025) Schlaich MP, Mahfoud F, Böhm M, Narkiewicz K, Ruilope L, Williams B, Mancia G, et al. Journal article Sex stratified analysis of patients with resistant hypertension from the Global SYMPLICITY Registry of renal denervation (2025) Mihailidou AS, Mahfoud F, Schlaich M, Schmieder R, Narkiewicz K, Ruilope L, Fahy M, et al. Journal article Complications After Surgery for Anorectal Malformations: An ARM-Net consortium Registry Study (2025) van der Steeg HJ, Hageman IC, Morandi A, Amerstorfer EE, Sloots CE, Jenetzky E, Stenström P, et al. Journal article A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. (2025) Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, et al. Journal article Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension Study (2025) Biedermann L, Schlag C, Straumann A, Lucendo AJ, Miehlke S, Vieth M, Santander C, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum